572 related articles for article (PubMed ID: 31654287)
1. Physiologically Based Pharmacokinetic Modeling of Oxycodone in Children to Support Pediatric Dosing Optimization.
Zheng L; Xu M; Tang SW; Song HX; Jiang XH; Wang L
Pharm Res; 2019 Oct; 36(12):171. PubMed ID: 31654287
[TBL] [Abstract][Full Text] [Related]
2. PBPK and its Virtual Populations: the Impact of Physiology on Pediatric Pharmacokinetic Predictions of Tramadol.
T'jollyn H; Vermeulen A; Van Bocxlaer J
AAPS J; 2018 Nov; 21(1):8. PubMed ID: 30498862
[TBL] [Abstract][Full Text] [Related]
3. Model qualification of the PK-Sim® pediatric module for pediatric exposure assessment of CYP450 metabolized compounds.
Yun YE; Edginton AN
J Toxicol Environ Health A; 2019; 82(14):789-814. PubMed ID: 31405354
[TBL] [Abstract][Full Text] [Related]
4. A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling for the Prediction of Drug Clearance From Neonates to Adolescents.
Mahmood I; Tegenge MA
J Clin Pharmacol; 2019 Feb; 59(2):189-197. PubMed ID: 30192373
[TBL] [Abstract][Full Text] [Related]
5. Maturation of Oxycodone Pharmacokinetics in Neonates and Infants: a Population Pharmacokinetic Model of Three Clinical Trials.
Välitalo P; Kokki M; Ranta VP; Olkkola KT; Hooker AC; Kokki H
Pharm Res; 2017 May; 34(5):1125-1133. PubMed ID: 28205004
[TBL] [Abstract][Full Text] [Related]
6. Develop adult extrapolation to pediatrics and pediatric dose optimization based on the physiological pharmacokinetic model of azithromycin.
Liang L; Li W; Zhang Z; Li D; Pu S; Xiang R; Zhai F
Biopharm Drug Dispos; 2023 Jun; 44(3):245-258. PubMed ID: 37080927
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of Physiologically Based Pharmacokinetic Model of Levetiracetam to Predict Exposure and Dose Optimization in Pediatrics.
Shao W; Shen C; Wang W; Sun H; Wang X; Geng K; Wang X; Xie H
J Pharm Sci; 2023 Oct; 112(10):2667-2675. PubMed ID: 37023853
[TBL] [Abstract][Full Text] [Related]
8. Investigating the Role of Altered Systemic Albumin Concentration on the Disposition of Theophylline in Adult and Pediatric Patients with Asthma by Using the Physiologically Based Pharmacokinetic Approach.
Rasool MF; Khalid R; Imran I; Majeed A; Saeed H; Alasmari F; Alanazi MM; Alqahtani F
Drug Metab Dispos; 2020 Jul; 48(7):570-579. PubMed ID: 32393652
[TBL] [Abstract][Full Text] [Related]
9. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
[TBL] [Abstract][Full Text] [Related]
10. The use of PBPK modeling across the pediatric age range using propofol as a case.
Michelet R; Van Bocxlaer J; Allegaert K; Vermeulen A
J Pharmacokinet Pharmacodyn; 2018 Dec; 45(6):765-785. PubMed ID: 30298439
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of oxycodone in children 6 months to 7 years old.
El-Tahtawy A; Kokki H; Reidenberg BE
J Clin Pharmacol; 2006 Apr; 46(4):433-42. PubMed ID: 16554451
[TBL] [Abstract][Full Text] [Related]
12. Application of a Physiologically Based Pharmacokinetic Model to Characterize Time-dependent Metabolism of Voriconazole in Children and Support Dose Optimization.
Zhang Y; Zhao S; Wang C; Zhou P; Zhai S
Front Pharmacol; 2021; 12():636097. PubMed ID: 33815119
[No Abstract] [Full Text] [Related]
13. Characterization and validation of a pharmacokinetic model for controlled-release oxycodone.
Mandema JW; Kaiko RF; Oshlack B; Reder RF; Stanski DR
Br J Clin Pharmacol; 1996 Dec; 42(6):747-56. PubMed ID: 8971431
[TBL] [Abstract][Full Text] [Related]
14. Physiologically-Based Pharmacokinetic Modeling of Tenofovir Disoproxil Fumarate in Pregnant Women.
Zhang X; Luo T; Yang H; Ma WY; He Q; Xu M; Yang Y
Curr Drug Metab; 2023; 23(14):1115-1123. PubMed ID: 36718061
[TBL] [Abstract][Full Text] [Related]
15. Predictive Performance of Physiology-Based Pharmacokinetic Dose Estimates for Pediatric Trials: Evaluation With 10 Bayer Small-Molecule Compounds in Children.
Ince I; Dallmann A; Frechen S; Coboeken K; Niederalt C; Wendl T; Block M; Meyer M; Eissing T; Burghaus R; Lippert J; Willmann S; Schlender JF
J Clin Pharmacol; 2021 Jun; 61 Suppl 1(Suppl 1):S70-S82. PubMed ID: 34185905
[TBL] [Abstract][Full Text] [Related]
16. Physiologically-Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome.
van Hoogdalem MW; Johnson TN; McPhail BT; Kamatkar S; Wexelblatt SL; Ward LP; Christians U; Akinbi HT; Vinks AA; Mizuno T
Clin Pharmacol Ther; 2022 Feb; 111(2):496-508. PubMed ID: 34679189
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Pediatric Rectal Absorption, Drug Disposition, and Sedation Level for Midazolam Gel Using Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling.
Zhu J; Zhou S; Wang L; Zhao Y; Wang J; Zhao T; Li T; Shao F
Mol Pharm; 2024 May; 21(5):2187-2197. PubMed ID: 38551309
[TBL] [Abstract][Full Text] [Related]
18. Simulation of the pharmacokinetics of bisoprolol in healthy adults and patients with impaired renal function using whole-body physiologically based pharmacokinetic modeling.
Li GF; Wang K; Chen R; Zhao HR; Yang J; Zheng QS
Acta Pharmacol Sin; 2012 Nov; 33(11):1359-71. PubMed ID: 23085739
[TBL] [Abstract][Full Text] [Related]
19. Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data.
Hornik CP; Wu H; Edginton AN; Watt K; Cohen-Wolkowiez M; Gonzalez D
Clin Pharmacokinet; 2017 Nov; 56(11):1343-1353. PubMed ID: 28290120
[TBL] [Abstract][Full Text] [Related]
20. Development of a Physiologically Based Pharmacokinetic Model for Sinogliatin, a First-in-Class Glucokinase Activator, by Integrating Allometric Scaling, In Vitro to In Vivo Exploration and Steady-State Concentration-Mean Residence Time Methods: Mechanistic Understanding of its Pharmacokinetics.
Song L; Zhang Y; Jiang J; Ren S; Chen L; Liu D; Chen X; Hu P
Clin Pharmacokinet; 2018 Oct; 57(10):1307-1323. PubMed ID: 29626326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
